OssDsign AB (SE:OSSD)
:OSSD
Want to see SE:OSSD full AI Analyst Report?
OSSD Stock Chart & Stats
kr11.30
-kr0.12(-0.97%)
At close: 4:00 PM EST
kr11.30
-kr0.12(-0.97%)
Day’s Range― - ―
52-Week Rangekr3.34 - kr16.72
Previous CloseN/A
Volume95.81K
Average Volume (3M)297.02K
Market Cap
kr453.01M
Enterprise Valuekr286.46M
Total Cash (Recent Filing)kr170.48M
Total Debt (Recent Filing)kr1.16M
Price to Earnings (P/E)―
Beta-0.42
Next Earnings
Aug 18, 2026EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding110,625,916
10 Day Avg. Volume325,245
30 Day Avg. Volume297,022
Financial Highlights & Ratios
PEG Ratio3.07
Price to Book (P/B)4.04
Price to Sales (P/S)6.95
P/FCF Ratio-17.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.43
Revenue Forecast (FY)kr181.82M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetExtremely low leverage and substantial equity provide durable financial flexibility to fund R&D, commercial expansion, or absorb shocks without urgent refinancing. This reduces solvency risk, supports multi-quarter runway despite losses, and preserves strategic optionality for partnerships or M&A.
Very High Gross MarginsSustained gross margins north of ~95% indicate meaningful product differentiation and pricing power from proprietary implants and materials. That structural margin advantage allows eventual operating leverage to flow to profits if overheads are controlled, making long-term unit economics attractive.
Historical Revenue Scaling / Product TractionMaterial multi-year revenue growth shows the company has achieved meaningful commercial traction and adoption in its clinical markets. A proven ability to scale sales and distribution is a durable foundation for future profitability once cost structure normalizes or incremental volumes drive operating leverage.
Bears Say
Negative Operating And Free Cash FlowPersistent negative OCF and FCF represent structural cash burn that will require ongoing financing or material margin improvement. Cash deficits constrain reinvestment, increase dilution or refinancing risk over months, and mean the business cannot self-fund growth until profitability or cash conversion reverses.
Sustained Operating LossesDespite high gross margins, large negative EBIT and net margins show the company has not converted product economics into operating profit. Continued structural losses depress returns and require either ongoing external capital or meaningful cost reduction and scale to achieve sustainable profitability.
Recent Revenue Stall / TTM DeclineA recent decline in TTM revenue after prior rapid scaling suggests a stall in growth or competitive/market headwinds. Slowing top-line momentum reduces the potential for operating leverage to fix margins and extends the timeline to profitability, raising the bar for execution over the next several months.
OssDsign AB News
OSSD FAQ
What was OssDsign AB’s price range in the past 12 months?
OssDsign AB lowest stock price was kr3.33 and its highest was kr16.72 in the past 12 months.
What is OssDsign AB’s market cap?
OssDsign AB’s market cap is kr453.01M.
When is OssDsign AB’s upcoming earnings report date?
OssDsign AB’s upcoming earnings report date is Aug 18, 2026 which is in 87 days.
How were OssDsign AB’s earnings last quarter?
OssDsign AB released its earnings results on May 05, 2026. The company reported -kr0.1 earnings per share for the quarter, the consensus estimate of -kr0.1 by kr0.
Is OssDsign AB overvalued?
According to Wall Street analysts OssDsign AB’s price is currently Overvalued.
Does OssDsign AB pay dividends?
OssDsign AB does not currently pay dividends.
What is OssDsign AB’s EPS estimate?
OssDsign AB’s EPS estimate is -0.17.
How many shares outstanding does OssDsign AB have?
OssDsign AB has 110,625,916 shares outstanding.
What happened to OssDsign AB’s price movement after its last earnings report?
OssDsign AB reported an EPS of -kr0.1 in its last earnings report, expectations of -kr0.1. Following the earnings report the stock price went up 2.256%.
Which hedge fund is a major shareholder of OssDsign AB?
Currently, no hedge funds are holding shares in SE:OSSD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OssDsign AB
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.
Technical Analysis
Paxman AB
―
Senzime AB
―
Bactiguard Holding AB
―
C-Rad AB Class B
―
Sedana Medical AB
―